This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Yonsei University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Dong Ik Kim
Introduction
Dong Ik Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of vascular diseases. His innovative approach has led to the development of a unique therapeutic method that addresses critical health issues.
Latest Patents
Dong Ik Kim holds a patent for a method aimed at treating vascular stenosis or occlusive disease caused by thrombi. The patent, titled "Method for treating vascular stenosis or occlusive disease due to thrombi by administering a saxatilin-fc fusion protein," describes a saxatilin derivative with an increased half-life. This derivative exhibits thrombolytic abilities similar to that of saxatilin, the original protein. It effectively dissolves blood clots in animal models, providing a long-lasting solution for patients suffering from various vascular diseases.
Career Highlights
Throughout his career, Dong Ik Kim has worked with esteemed institutions such as Yonsei University and the Korea Institute of Science and Technology. His research has focused on enhancing the efficacy of treatments for cerebrovascular, cardiovascular, and peripheral vascular diseases. His innovative methods have the potential to significantly improve patient outcomes.
Collaborations
Dong Ik Kim has collaborated with notable colleagues, including Ji Hoe Heo and Il Kwon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Dong Ik Kim's contributions to medical science through his innovative patent demonstrate his commitment to improving healthcare. His work has the potential to transform the treatment of vascular diseases, making a lasting impact on patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
